Trends in ecstasy use in the United States from 1995 to 2001: Comparison with marijuana users and association with other drug use

Experimental and Clinical Psychopharmacology

Volumn 13, Issue 3, 2005, Pages 244-252

  Martins, Silvia S ^a   Mazzotti, Guido ^a   Chilcoat, Howard D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; DIAMORPHINE; LYSERGIDE;

ADOLESCENT; ADULT; ARTICLE; CANNABIS ADDICTION; DRUG ABUSE; EPIDEMIC; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE DRUG ABUSE; PREVALENCE; SUBSTANCE ABUSE; UNITED STATES;

AMPHETAMINE-RELATED DISORDERS; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; MARIJUANA SMOKING; UNITED STATES;

EID: 24944492394     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.13.3.244     Document Type: Article

References (36)

1. Baggott, M. (2002). Preventing problems in ecstasy users; Reduce use to reduce harm. Journal of Psychoactive Drugs, 34, 145-162.
2. Beck, J., & Rosenbaum, M. (1994). Pursuit of ecstasy: The MDMA experience. Albany: State University of New York Press.
3. Boyd, C. J., McCabe, S. E., & d'Arcy, H. (2003). Ecstasy use among college undergraduates: Gender, race, and sexual identity. Journal of Substance Abuse Treatment, 24, 209-215.
4. Chilcoat, H. D., Lucia, V. C., & Breslau, N. (1999). Level of agreement between DIS and UM-CIDI substance use disorders: Implications for research. International Journal of Methods in Psychiatric Research, 8, 83-101.
5. Chromy, J., Davis, T., Packer, L., & Gfroerer, J. (2002). Mode effects on substance use measures: Comparison of the 1999 CAI and PAPI data. In J. Gfroerer, J. Eyerman, & J. Chromy (Eds.), Redesigning an ongoing National Household Survey: Methodological issues (DHHS Publication No. SMA 03-3768, pp. 135-157). Rockville, MD: Substance Abuse and Mental Health Services Administration.
6. Çorapçioglu, A., & Ogel, K. (2004). Factors associated with ecstasy use in Turkish students. Addiction, 99, 67-76.
7. de Almeida, S. P., & Silva, M. T. A. (2003). Ecstasy (MDMA): Effects and patterns of use reported by users in Sao Paulo. Revista Brasileira de Psiquiatria, 25, 11-17.
8. Degenhardt, L., Barker, B., & Topp, L. (2004). Patterns of ecstasy use in Australia: Findings from a National Household Survey. Addiction, 99, 187-193.
9. European Monitoring Centre for Drugs and Drug Addiction. (2003). Annual Report 2003: The state of the drugs problems in the European Union and Norway. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction.
10. Fendrich, M., Wislar, J. S., Johnson, T. P., & Hubbell, A. (2003). A contextual profile of club drug use among adults in Chicago. Addiction, 98, 1693-1703.
11. Ferrence, R. (2001). Diffusion theory and drug use. Addiction, 96, 165-173.
12. Gross, S. R., Barrett, S. P., Shestowsky, J. S., & Pihl, R. O. (2002). Ecstasy and drug consumption patterns: A Canadian rave population study. Canadian Journal of Psychiatry, 47, 546-551.
13. Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (2000). Monitoring the Future: National Survey results on adolescent drug use: Overview of key findings, 1999 (NIH Publication No. 00-4690). Bethesda, MD: National Institute on Drug Abuse.
14. Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (2001a). Monitoring the Future: National survey results on drug use, 1975-2000. Volume I: Secondary school students (NIH Publication No. 02-5106). Bethesda, MD: National Institute on Drug Abuse.
15. Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (2001b). Monitoring the Future: National survey results on drug use, 1975-2000. Volume II: College students and young adults ages 19-40 (NIH Publication No. 02-5107). Bethesda, MD: National Institute on Drug Abuse.
16. Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (2002). Monitoring the Future: National results on adolescent drug use. Overview of key findings, 2001 (NIH Publication No. 02-5105). Bethesda, MD: National Institute on Drug Abuse.
17. Johnston, L. D., O'Malley, P, M., Bachman, J. G., & Schulenberg, J. E. (2003, December). Ecstasy use falls for second year in a row, overall teen drug use drops. Retrieved February 12, 2004, from University of Michigan, News and Information Services Web site: http://www.monitoringthefuture.org
18. Landry, M. J. (2002). MDMA: A review of epidemiologic data. Journal of Psychoactive Drugs, 34, 163-169.
19. Lenton, S., Boys, A., & Norcross, K. (1997). Raves, drugs, and experience: Drug use by a sample of people who attend raves in Western Australia. Addiction, 92, 1327-1337.
20. Liechti, M. E., Gamma, A., & Vollenweider, F. X. (2001). Gender differences in the subjective effects of MDMA. Psychopharmacology, 154, 161-168.
21. Montoya, A. G., Sorrentino, R., Lukas, S. E., & Price, B. H. (2002). Long-term neuropsychiatric consequences of "ecstasy" (MDMA): A review. Harvard Review of Psychiatry, 10, 212-220.
22. Morland, J. (2000). Toxicity of drug abuse-Amphetamine designer drugs (ecstasy): Mental effects and consequences of a single dose. Toxicology Letters, 112-113, 147-152.
23. Morral, A. R., McCaffrey, D. F., & Chien, S. (2003). Measurement of adolescent drug use. Journal of Psychoactive Drugs, 35, 301-309.
24. Parker, H., Aldridge, J., & Measham, F. (1998). Illegal leisure: The normalization of adolescent recreational drug use. London: Routledge.
25. Parrott, A. C., Sisk, E., & Turner, J. J. D. (2000). Psychobiological problems in heavy "ecstasy" (MDMA) polydrug users. Drug and Alcohol Dependence, 60, 105-110.
26. Pedersen, W., & Skrondal, A. (1999). Ecstasy and new patterns of drug use: A normal population study. Addiction, 94, 1695-1706.
27. Peroutka, S. J., Newman, J. H., & Harris, H. (1988). Recreational use of 3,4 methylenedioxymethamphetamine (MDMA, ecstasy). Neuropsychopharmacology, 1, 273-277.
28. Schifano, F., DiFuria, L., Forza, G., Minicuci, N., & Bricolo, R. (1998). MDMA ("ecstasy") consumption in the context of polydrug abuse: A report on 150 patients. Drug and Alcohol Dependence, 52, 85-90.
29. Stata Corporation. (2003). Stata Statistical Software: Release 8.0. College Station, TX: Author.
30. Substance Abuse and Mental Health Services Administration. (2002). Results from the 2001 National Household Survey on Drug Abuse: Volume I. Summary of national findings (DHHS Publication No. SMA 02-3758, NHSDA Series H-17). Rockville, MD: Author.
31. Substance Abuse and Mental Health Services Administration (2003). Emergency department trends from Drug Abuse Warning Network, final estimates: 1995-2002 (DHHS Publication No. SMA 03-3780, DAWN Series D-24). Rockville, MD: Author.
32. Topp, L., Hando, J., Dillon, P., Roche, A., & Solowij, N. (1999). Ecstasy use in Australia: Patterns of use and associated harm. Drug and Alcohol Dependence, 55, 105-115.
33. United Nations Office for Drug Control and Drug Prevention. (2001). The 2001 Lebanon RSA report. Substance use and misuse in Lebanon. Beirut, Lebanon: Institute for Development Research and Applied Care.
34. von Sydow, K., Lieb, R., Pfister, H., Höfler, M., & Wittchen, H. U. (2002). Use, abuse, and dependence of ecstasy and related drugs in adolescents and young adults: A transient phenomenon? Results from a longitudinal community study. Drug and Alcohol Dependence, 66, 147-159.
35. Walters, S. T., Foy, B. D., & Castro, R. J. (2002). The agony of ecstasy: Responding to growing MDMA use among college students. Journal of American College Health, 51, 139-141.
36. Wilkins, C., Bhatta, K., Pledger, M., & Casswell, S. (2003). Ecstasy use in New Zealand: Findings from the 1998 and 2001 National Drug Surveys [Electronic version]. The New Zealand Medical Journal, 116, 1-10.